Resumo
The synthesis and anti-microbial activity of new spiro-β-lactams is reported. The design of the new molecules was based on the structural modulation of two previously identified lead spiro-penicillanates with dual activity against HIV and Plasmodium. The spiro-β-lactams synthesized were assayed for their in vitro activity against HIV-1, providing relevant structure-activity relationship information. Among the tested compounds, two spirocyclopentenyl-β-lactams were identified as having remarkable nanomolar activity against HIV-1. Additionally, the same molecules showed promising antiplasmodial activity, inhibiting both the hepatic and blood stages of Plasmodium infection.
Idioma original | ???core.languages.en_GB??? |
---|---|
Número do artigo | 113439 |
Revista | European Journal of Medicinal Chemistry |
Volume | 219 |
DOIs | |
Estado da publicação | ???researchoutput.status.published??? - 5 jul. 2021 |